Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

Stopped Research cancelled.

Conditions

• Breast Cancer Female

Interventions

• DRUG: oral microencapsulated diindolylmethane
• OTHER: laboratory biomarker analysis

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

• [object Object]